Biochemical characterization of chymotrypsins from the hepatopancreas of Japanese sea bass (Lateolabrax japonicus).

J Agric Food Chem

College of Biological Engineering, The Key Laboratory of Science and Technology for Aquaculture and Food Safety, Jimei University, Jimei, Xiamen, China 361021.

Published: July 2010

Two chymotrypsins (chymotrypsins A and B) have been purified to homogeneity from the hepatopancreas of Japanese sea bass ( Lateolabrax japonicus ) by ammonium sulfate fractionation and chromatographies on DEAE-Sepharose and Phenyl-Sepharose. Two-dimensional electrophoresis (2-DE) analysis revealed that the molecular masses of chymotrypsins A and B were approximately 27.0 and 27.5 kDa, respectively. Their respective isoelectric points were 8.0 and 7.0. Purified chymotrypsins also revealed a single band on native-PAGE, whereas their mobilities were quite different. Optimum temperature and pH of chymotrypsins A and B were 45 degrees C and 8.0, respectively. Both enzymes were strongly inhibited by chymostatin, phenylmethanesulfonyl fluoride (PMSF), and Pefabloc SC, but slightly inhibited by metalloproteinase inhibitor of 1,10-phenanthroline and EDTA. Using Suc-Leu-Leu-Val-Tyr-MCA as substrate, apparent K(m) values of chymotrypsins A and B were 0.8 and 1.1 microM and k(cat) values were 2.7 and 2.0 s(-1), respectively. The N-terminal amino acid sequences of chymotrypsins A and B were determined to the 21st and 18th residues, respectively, and were identical. These sequences exhibited high identities to chymotrypsins from other animals. The digestive effect of the two chymotrypsins on myofibrillar proteins indicated their effectiveness in the degradation of food proteins.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jf101970hDOI Listing

Publication Analysis

Top Keywords

chymotrypsins
10
hepatopancreas japanese
8
japanese sea
8
sea bass
8
bass lateolabrax
8
lateolabrax japonicus
8
biochemical characterization
4
characterization chymotrypsins
4
chymotrypsins hepatopancreas
4
japonicus chymotrypsins
4

Similar Publications

Differential Activity and Expression of Proteasome in Seminiferous Epithelium During Mouse Spermatogenesis.

Int J Mol Sci

January 2025

Laboratorio de Biología de la Reproducción, Departamento Biomédico, Facultad de Ciencias de la Salud, Universidad de Antofagasta, Antofagasta 1240000, Chile.

Proteasome-mediated protein degradation is essential for maintaining cellular homeostasis, particularly during spermatogenesis, where extensive cellular transformations, such as spermatid differentiation, require precise protein turnover. A key player in this process is the ubiquitin-proteasome system (UPS). This study aimed to investigate proteasome enzymatic activity at different stages of the spermatogenic cycle within the seminiferous tubules of mice and explore the regulatory mechanisms that influence its proteolytic function.

View Article and Find Full Text PDF

Chemical composition and techno-functional properties of high-purity water-soluble keratein and its enzymatic hydrolysates.

Food Chem

December 2024

Department of Food Chemistry, Technology and Biotechnology, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Narutowicza Street 11/12, 80-233, Poland. Electronic address:

This study compared the effectiveness of urea-containing and urea-free L-cysteine solutions in extracting high-quality feather keratin and evaluated commercial proteases for producing keratin-derived bioactive peptides. The urea-assisted extraction was crucial for achieving high structural integrity and yield of soluble keratin. The keratin isolate exhibited oil-holding capacity of 9.

View Article and Find Full Text PDF

Development of novel epoxyketone macrocyclic peptidyl proteasome inhibitors through OPA-mediated one-step cyclization of unprotected peptides.

Bioorg Chem

January 2025

Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province School of Medicine Hangzhou City University China; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058 Zhejiang Province, China. Electronic address:

Cyclization is a pivotal strategy for enhancing the drug-like characteristics of polypeptides. To develop potent and metabolically stable proteasome inhibitors, we generated a macrocyclic peptide skeleton using a straightforward and efficient cyclization strategy. Subsequent stability assessments confirmed the practicality of this approach.

View Article and Find Full Text PDF

Peptide mapping analysis of synthetic semaglutide and liraglutide for generic development of drugs originating from recombinant DNA technology.

J Pharm Biomed Anal

January 2025

College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea; Department of Global Innovative Drugs, The Graduate School of Chung-Ang University, Seoul 06974, Republic of Korea. Electronic address:

Semaglutide and liraglutide are long-acting glucagon-like peptide-1 receptor agonists used to treat type-2 diabetes and obesity. Recent advances in peptide synthesis and analytical technologies have enabled the development of synthetic generic peptide for reference listed drugs (RLD) originating from recombinant DNA (rDNA) technology. Since the original semaglutide and liraglutide were produced through rDNA technology, there has been great interest in developing their synthetic peptides as generic versions of the original drugs.

View Article and Find Full Text PDF

Background: Ensitrelvir is a novel SARS-CoV-2 3-chymotrypsin-like protease inhibitor, similar to nirmatrelvir/ritonavir. Several case reports have demonstrated the efficacy of 3-chymotrypsin-like protease inhibitors in treating prolonged coronavirus disease 2019 (COVID-19) in immunocompromised patients. Tacrolimus (TAC) is a widely used immunosuppressive agent whose blood level can increase significantly due to the inhibition of cytochrome P450 3A (CYP3A) and P-glycoprotein by nirmatrelvir/ritonavir.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!